MYGN Stock-Based Compensation
Myriad Genetics Inc · Stock-Based Compensation
MYGN Stock-Based Compensation
Latest reported$28.70Mperiod ending
MYGN Stock-Based Comp ($0.00 → $28.70M)
Annual stock-based compensation
High-resolution chart · PNG
MYGN stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 35,200,000 | |
| 49,800,000 | |
| 40,700,000 | |
| 38,100,000 | |
| 36,300,000 | |
| 24,300,000 | |
| 25,200,000 | |
| 33,500,000 | |
| 27,100,000 | |
| 29,900,000 | |
| 31,600,000 | |
| 45,700,000 | |
| 27,100,000 | |
| 26,600,000 | |
| 26,275,000 | |
| 25,088,000 | |
| 22,776,000 | |
| 25,682,000 | |
| 15,415,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |